12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Andrus Reo, Oncolytics deal

Oncolytics granted Andrus Reo rights in Russia and the Commonwealth of Independent States (CIS) to Reolysin. The formulation...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >